ERBB2 and breast cancer: Dilorenzo et al. [69] investigated the value of MRI background parenchymal enhancement (BPE) for the differential diagnosis of different breast cancer subtypes and showed that mild BPE suggested Luminal B or HER2-negative subtypes, while severe BPE suggested triple-negative breast cancer.